Five PE shops study Tailwind's VersaPharm
Five private equity firms are looking at the generic drug maker VersaPharm, which is being sold by Tailwind Capital, two sources said.
1 May 2014•1 min read
Five private equity firms are looking at the generic drug maker VersaPharm, which is being sold by Tailwind Capital, two sources said.
